Advanced search
Publication Cover
Orbit
The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery
Volume 42, 2023 - Issue 4
Submit an article Journal homepage
300
Views
2
CrossRef citations to date
0
Altmetric
Original Investigation

Differential effects of teprotumumab treatment based on fat-to-muscle ratio in patients with thyroid eye disease

Michelle A. Tinga Division of Oculofacial Plastic and Reconstructive Surgery, Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California San Diego, La Jolla, California, USACorrespondence[email protected]
View further author information
,
Daniel James Ozzelloa Division of Oculofacial Plastic and Reconstructive Surgery, Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California San Diego, La Jolla, California, USAView further author information
,
Nicole J. Topilowa Division of Oculofacial Plastic and Reconstructive Surgery, Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California San Diego, La Jolla, California, USAView further author information
,
Jin Sook Yoona Division of Oculofacial Plastic and Reconstructive Surgery, Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California San Diego, La Jolla, California, USA;b Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine, Seoul, KoreaView further author information
,
Catherine Y. Liua Division of Oculofacial Plastic and Reconstructive Surgery, Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California San Diego, La Jolla, California, USAView further author information
,
Bobby S. Korna Division of Oculofacial Plastic and Reconstructive Surgery, Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California San Diego, La Jolla, California, USA;c Division of Plastic and Reconstructive Surgery, Department of Surgery, UC San Diego, La Jolla, California, USAView further author information
&
Don O. Kikkawaa Division of Oculofacial Plastic and Reconstructive Surgery, Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California San Diego, La Jolla, California, USA;c Division of Plastic and Reconstructive Surgery, Department of Surgery, UC San Diego, La Jolla, California, USAView further author information
 show all
Pages 418-425 | Received 12 Apr 2022, Accepted 01 Sep 2022, Published online: 12 Sep 2022

References

  • Douglas RS, Kahaly GJ, Patel A, Sile S, Thompson EHZ, Perdok R, et al. Teprotumumab for the treatment of active thyroid eye disease. N Engl J Med. January 23, 2020;382(4):341–352. doi:10.1056/NEJMoa1910434.
  • Douglas RS. Teprotumumab, an insulin-like growth factor-1 receptor antagonist antibody, in the treatment of active thyroid eye disease: a focus on proptosis. Eye Lond Engl. February, 2019;33(2):183–190.
  • Ozzello DJ, Kikkawa DO, Korn BS. Early experience with teprotumumab for chronic thyroid eye disease. Am J Ophthalmol Case Rep. September 2020;19:100744. doi:10.1016/j.ajoc.2020.100744.
  • Ozzello DJ, Dallalzadeh LO, Liu CY. Teprotumumab for chronic thyroid eye disease. Orbit.October 2022;41(5):539–546. doi:10.1080/01676830.2021.1933081.
  • Kendler DL, Lippa J, Rootman J. The initial clinical characteristics of Graves’ orbitopathy vary with age and sex. Arch Ophthalmol Chic Ill 1960. Febuary 1993;111(2):197–201. doi:10.1001/archopht.1993.01090020051022.
  • Uddin JM, Rubinstein T, Hamed-Azzam S. Phenotypes of thyroid eye disease. Ophthal Plast Reconstr Surg. August 2018;34(4S Suppl 1):S28–33. doi:10.1097/IOP.0000000000001147.
  • Dolman PJ. Grading severity and activity in thyroid eye disease. Ophthal Plast Reconstr Surg. August 2018;34(4S Suppl 1):S34–40. doi:10.1097/IOP.0000000000001150.
  • Nunery WR, Tao J. Thyroid orbitopathy. Ophthalmology. March 2007;114(3):621–622. author reply 622. doi:10.1016/j.ophtha.2006.08.026.
  • Nunery WR, Martin RT, Heinz GW, Gavin TJ. The association of cigarette smoking with clinical subtypes of ophthalmic Graves’ disease. Ophthal Plast Reconstr Surg. June 1993;9(2):77–82. doi:10.1097/00002341-199306000-00001.
  • Nunery WR. Ophthalmic Graves’ disease: a dual theory of pathogenesis. Ophthalmol Clin North Am. 1991;4:73–87.
  • Ugradar S, Rootman DB. Orbital fat expansion in thyroid eye disease is related to age. Eur J Ophthalmol. September 2020;30(5):1004–1007. doi:10.1177/1120672119852322.
  • Jain AP, Gellada N, Ugradar S, Kumar A, Kahaly G, Douglas R. Teprotumumab reduces extraocular muscle and orbital fat volume in thyroid eye disease. Br J Ophthalmol. 2020;106(2):165–171. doi:10.1136/bjophthalmol-2020-317806.
  • Forbes G, Gorman CA, Gehring D, Baker HL. Computer analysis of orbital fat and muscle volumes in Graves ophthalmopathy. AJNR Am J Neuroradiol. June 1983;4(3):737–740.
  • Dik WA, Virakul S, van Steensel L. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves’ ophthalmopathy. Exp Eye Res. January 2016;142:83–91. doi:10.1016/j.exer.2015.02.007.
  • Pritchard J, Han R, Horst N, Cruikshank WW, Smith TJ. Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves’ disease is mediated through the insulin-like growth factor I receptor pathway. J Immunol Baltim Md 1950. June 15, 2003;170(12):6348–6354.
  • Pritchard J, Horst N, Cruikshank W, Smith TJ. Igs from patients with Graves’ disease induce the expression of T cell chemoattractants in their fibroblasts. J Immunol Baltim Md 1950. Jan 15, 2002;168(2):942–950.
  • Tsui S, Naik V, Hoa N, Hwang CJ, Afifiyan NF, Sinha Hikim A, et al. Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves’ disease. J Immunol Baltim Md 1950. Sep 15, 2008;181(6):4397–4405.
  • Hwang CJ, Eftekhari K. Teprotumumab for thyroid eye disease. Int Ophthalmol Clin. 2020;60(2):47–55. doi:10.1097/IIO.0000000000000307.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.